BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eaton T, Young P, Milne D, Wells AU. Six-Minute Walk, Maximal Exercise Tests: Reproducibility in Fibrotic Interstitial Pneumonia. Am J Respir Crit Care Med 2005;171:1150-7. [DOI: 10.1164/rccm.200405-578oc] [Cited by in Crossref: 161] [Cited by in F6Publishing: 51] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Manali ED, Lyberopoulos P, Triantafillidou C, Kolilekas LF, Sotiropoulou C, Milic-Emili J, Roussos C, Papiris SA. MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study. BMC Pulm Med 2010;10:32. [PMID: 20509928 DOI: 10.1186/1471-2466-10-32] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
2 Buch MH, Denton CP, Furst DE, Guillevin L, Rubin LJ, Wells AU, Matucci-Cerinic M, Riemekasten G, Emery P, Chadha-Boreham H, Charef P, Roux S, Black CM, Seibold JR. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test. Ann Rheum Dis 2007;66:169-73. [PMID: 16868020 DOI: 10.1136/ard.2006.054866] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
3 Taveira-DaSilva AM, Pacheco-Rodriguez G, Moss J. The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. Lymphat Res Biol. 2010;8:9-19. [PMID: 20235883 DOI: 10.1089/lrb.2009.0024] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
4 Swigris JJ, Wamboldt FS, Behr J, du Bois RM, King TE, Raghu G, Brown KK. The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax 2010;65:173-7. [PMID: 19996335 DOI: 10.1136/thx.2009.113498] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 6.3] [Reference Citation Analysis]
5 Agrawal MB, Awad NT. Correlation between Six Minute Walk Test and Spirometry in Chronic Pulmonary Disease. J Clin Diagn Res 2015;9:OC01-4. [PMID: 26435980 DOI: 10.7860/JCDR/2015/13181.6311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
6 Bourbonnais JM, Malaisamy S, Dalal BD, Samarakoon PC, Parikh SR, Samavati L. Distance saturation product predicts health-related quality of life among sarcoidosis patients. Health Qual Life Outcomes 2012;10:67. [PMID: 22694853 DOI: 10.1186/1477-7525-10-67] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
7 Glasgow CG, Steagall WK, Taveira-Dasilva A, Pacheco-Rodriguez G, Cai X, El-Chemaly S, Moses M, Darling T, Moss J. Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies. Respir Med 2010;104 Suppl 1:S45-58. [PMID: 20630348 DOI: 10.1016/j.rmed.2010.03.017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
8 Nakazawa A, Cox NS, Holland AE. Current best practice in rehabilitation in interstitial lung disease. Ther Adv Respir Dis 2017;11:115-28. [PMID: 28150539 DOI: 10.1177/1753465816676048] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
9 Nakazawa A, Dowman LM, Cox NS, Brazzale DJ, McDonald CF, Hill CJ, Lee A, Holland AE. Prescribing walking training in interstitial lung disease from the 6-minute walk test. Physiother Theory Pract 2022;:1-5. [PMID: 35073825 DOI: 10.1080/09593985.2022.2029992] [Reference Citation Analysis]
10 Resqueti VR, Oliveira GWDS, Dourado Junior ME, Andrade ADD, Casan P, Fregonezi GADF. Confiabilidade do teste da caminhada de seis minutos em pacientes com miastenia gravis generalizada. Fisioter Pesqui 2009;16:223-8. [DOI: 10.1590/s1809-29502009000300006] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788-824. [PMID: 21471066 DOI: 10.1164/rccm.2009-040gl] [Cited by in Crossref: 4088] [Cited by in F6Publishing: 1877] [Article Influence: 371.6] [Reference Citation Analysis]
12 Gupta R, Baughman RP, Nathan SD, Wells AU, Kouranos V, Alhamad EH, Culver DA, Barney J, Carmona EM, Cordova FC, Huitema M, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Price LC, Wort SJ, Shlobin OA. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry. Respiratory Medicine 2022;196:106801. [DOI: 10.1016/j.rmed.2022.106801] [Reference Citation Analysis]
13 Rush EC, Crook N, Simmons D. Relationships between a walk test, body size and metabolic risk among a New Zealand Māori community. Annals of Human Biology 2009;37:117-27. [DOI: 10.3109/03014460903264251] [Reference Citation Analysis]
14 Matsuda T, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, Nishimura K, Nishiyama O, Sakamoto K, Hasegawa Y. Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis. Intern Med 2017;56:1637-44. [PMID: 28674350 DOI: 10.2169/internalmedicine.56.7019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
15 Couillard A. Les facteurs pronostiques dans la BPCO : la tête, les jambes et le souffle ! Revue des Maladies Respiratoires 2011;28:174-86. [DOI: 10.1016/j.rmr.2010.09.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
16 Deconinck B, Verschakelen J, Coolen J, Verbeken E, Verleden G, Wuyts W. Diagnostic workup for diffuse parenchymal lung disease: schematic flowchart, literature review, and pitfalls. Lung 2013;191:19-25. [PMID: 23149802 DOI: 10.1007/s00408-012-9433-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
17 Olson AL, Swigris JJ, Brown KK. Clinical trials and tribulations--lessons from pulmonary fibrosis. QJM 2012;105:1043-7. [PMID: 22647760 DOI: 10.1093/qjmed/hcs066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
18 Mori S. Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis. Clin Med Insights Circ Respir Pulm Med 2015;9:41-9. [PMID: 26401101 DOI: 10.4137/CCRPM.S23288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
19 Reinaldo GP, Araújo CLP, Schneider B, Florian J, Machado SC, Hochhegger B, Dal Lago P. Validity and reliability of the Glittre-ADL test in individuals with idiopathic pulmonary fibrosis. Physiotherapy Theory and Practice. [DOI: 10.1080/09593985.2022.2032510] [Reference Citation Analysis]
20 Oursler KK, Tate JP, Gill TM, Crothers K, Brown TT, Crystal S, Womack J, Leaf DA, Sorkin JD, Justice AC. Association of the veterans aging cohort study index with exercise capacity in HIV-infected adults. AIDS Res Hum Retroviruses 2013;29:1218-23. [PMID: 23705911 DOI: 10.1089/AID.2012.0388] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
21 Campo M, Oursler KK, Huang L, Goetz MB, Rimland D, Hoo GS, Brown ST, Rodriguez-Barradas MC, Au D, Akgün KM, Shahrir S, Crothers K. Association of chronic cough and pulmonary function with 6-minute walk test performance in HIV infection. J Acquir Immune Defic Syndr 2014;65:557-63. [PMID: 24346638 DOI: 10.1097/QAI.0000000000000086] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
22 Triantafillidou C, Manali E, Lyberopoulos P, Kolilekas L, Kagouridis K, Gyftopoulos S, Vougas K, Kotanidou A, Alchanatis M, Karakatsani A, Papiris SA. The Role of Cardiopulmonary Exercise Test in IPF Prognosis. Pulm Med 2013;2013:514817. [PMID: 24288606 DOI: 10.1155/2013/514817] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
23 Jin J, Zhu L, Tong X, Ness KK. T-type Corrected-Loss Estimation for Error-in-Variable Model. Commun Stat Theory Methods 2017;46:616-27. [PMID: 27840548 DOI: 10.1080/03610926.2014.1002934] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Ikezoe K, Handa T, Tanizawa K, Chen-Yoshikawa TF, Kubo T, Aoyama A, Motoyama H, Hijiya K, Tokuda S, Nakatsuka Y, Yamamoto Y, Oshima A, Harashima SI, Nagai S, Hirai T, Date H, Chin K. Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease. PLoS One 2017;12:e0183171. [PMID: 28800589 DOI: 10.1371/journal.pone.0183171] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
25 Jackson RM, Glassberg MK, Ramos CF, Bejarano PA, Butrous G, Gómez-Marín O. Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis. Lung 2010;188:115-23. [PMID: 20012639 DOI: 10.1007/s00408-009-9209-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
26 Porteous MK, Rivera-Lebron BN, Kreider M, Lee J, Kawut SM. Determinants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation. Pulm Circ 2016;6:30-6. [PMID: 27076905 DOI: 10.1086/685022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
27 Stephen MJ, Emami K, Woodburn JM, Chia E, Kadlecek S, Zhu J, Pickup S, Ishii M, Rizi RR, Rossman M. Quantitative assessment of lung ventilation and microstructure in an animal model of idiopathic pulmonary fibrosis using hyperpolarized gas MRI. Acad Radiol 2010;17:1433-43. [PMID: 20934126 DOI: 10.1016/j.acra.2010.06.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
28 Chen LF, Wang CH, Chou PC, Ho SC, Joa WC, Sheng TF, Kuo HP. Association Between Emphysema Score, Six-Minute Walk and Cardiopulmonary Exercise Tests in COPD. Open Respir Med J 2012;6:104-10. [PMID: 23115601 DOI: 10.2174/1874306401206010104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
29 Chandel A, Pastre J, Valery S, King CS, Nathan SD. Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis. Thorax 2022:thoraxjnl-2021-218440. [PMID: 35332096 DOI: 10.1136/thoraxjnl-2021-218440] [Reference Citation Analysis]
30 Swigris JJ, Zhou X, Wamboldt FS, du Bois R, Keith R, Fischer A, Cosgrove GP, Frankel SK, Curran-Everett D, Brown KK. Exercise peripheral oxygen saturation (SpO2) accurately reflects arterial oxygen saturation (SaO2) and predicts mortality in systemic sclerosis. Thorax 2009;64:626-30. [PMID: 19359269 DOI: 10.1136/thx.2008.111393] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
31 Fernández Fabrellas E, Peris Sánchez R, Sabater Abad C, Juan Samper G. Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis. Med Sci (Basel) 2018;6:E51. [PMID: 29904028 DOI: 10.3390/medsci6020051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
32 Martinez FJ, Flaherty K. Pulmonary function testing in idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006;3:315-21. [PMID: 16738195 DOI: 10.1513/pats.200602-022TK] [Cited by in Crossref: 90] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
33 Alhamad EH, Shaik SA, Idrees MM, Alanezi MO, Isnani AC. Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis. BMC Pulm Med 2010;10:42. [PMID: 20696064 DOI: 10.1186/1471-2466-10-42] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
34 Fell CD, Liu LX, Motika C, Kazerooni EA, Gross BH, Travis WD, Colby TV, Murray S, Toews GB, Martinez FJ, Flaherty KR. The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009;179:402-7. [PMID: 19074597 DOI: 10.1164/rccm.200802-241OC] [Cited by in Crossref: 68] [Cited by in F6Publishing: 25] [Article Influence: 4.9] [Reference Citation Analysis]
35 Hsieh MH, Fang YF, Chung FT, Lee CS, Chang YC, Liu YZ, Wu CH, Lin HC. Distance-saturation product of the 6-minute walk test predicts mortality of patients with non-cystic fibrosis bronchiectasis. J Thorac Dis 2017;9:3168-76. [PMID: 29221293 DOI: 10.21037/jtd.2017.08.53] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
36 Visca D, Tsipouri V, Mori L, Firouzi A, Fleming S, Farquhar M, Leung E, Maher TM, Cullinan P, Hopkinson N, Wells AU, Banya W, Whitty JA, Adamali H, Spencer LG, Sestini P, Renzoni EA. Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial. Trials 2017;18:201. [PMID: 28454553 DOI: 10.1186/s13063-017-1912-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
37 Doyle TJ, Washko GR, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Divo MJ, Celli BR, Sciurba FC, Silverman EK, Hatabu H, Rosas IO, Hunninghake GM; COPDGene Investigators. Interstitial lung abnormalities and reduced exercise capacity. Am J Respir Crit Care Med 2012;185:756-62. [PMID: 22268134 DOI: 10.1164/rccm.201109-1618OC] [Cited by in Crossref: 71] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
38 Mossberg KA, Fortini E. Responsiveness and validity of the six-minute walk test in individuals with traumatic brain injury. Phys Ther 2012;92:726-33. [PMID: 22282772 DOI: 10.2522/ptj.20110157] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
39 Lancaster LH. Utility of the six-minute walk test in patients with idiopathic pulmonary fibrosis. Multidiscip Respir Med 2018;13:45. [PMID: 30559965 DOI: 10.1186/s40248-018-0158-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
40 Thomeer M, Grutters JC, Wuyts WA, Willems S, Demedts MG. Clinical use of biomarkers of survival in pulmonary fibrosis. Respir Res 2010;11:89. [PMID: 20584284 DOI: 10.1186/1465-9921-11-89] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
41 Ross RM, Murthy JN, Wollak ID, Jackson AS. The six minute walk test accurately estimates mean peak oxygen uptake. BMC Pulm Med. 2010;10:31. [PMID: 20504351 DOI: 10.1186/1471-2466-10-31] [Cited by in Crossref: 146] [Cited by in F6Publishing: 135] [Article Influence: 12.2] [Reference Citation Analysis]
42 Dale MT, McKeough ZJ, Munoz PA, Corte P, Bye PT, Alison JA. Functional exercise capacity and health-related quality of life in people with asbestos related pleural disease: an observational study. BMC Pulm Med 2013;13:1. [PMID: 23305075 DOI: 10.1186/1471-2466-13-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
43 Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD, Lama V, Kazerooni EA, Gross BH, Toews GB, Martinez FJ. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006;174:803-9. [PMID: 16825656 DOI: 10.1164/rccm.200604-488OC] [Cited by in Crossref: 224] [Cited by in F6Publishing: 100] [Article Influence: 14.0] [Reference Citation Analysis]
44 Kirkil G, Lower E, Baughman R. Advances in predicting patient survival in pulmonary sarcoidosis. Expert Opinion on Orphan Drugs 2021;9:113-22. [DOI: 10.1080/21678707.2021.1925107] [Reference Citation Analysis]
45 Naz I, Sahin H, Demirci Uçsular F, Yalnız E. A comparison trial of eight weeks versus twelve weeks of exercise program in interstitial lung diseases. Sarcoidosis Vasc Diffuse Lung Dis 2018;35:299-307. [PMID: 32476917 DOI: 10.36141/svdld.v35i4.6830] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Lederer DJ, Arcasoy SM, Wilt JS, D’Ovidio F, Sonett JR, Kawut SM. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174:659-664. [PMID: 16778159 DOI: 10.1164/rccm.200604-520oc] [Cited by in Crossref: 244] [Cited by in F6Publishing: 77] [Article Influence: 15.3] [Reference Citation Analysis]
47 Chenivesse C, Boulanger S, Langlois C, Wemeau-Stervinou L, Perez T, Wallaert B. Oxygen desaturation during a 6-minute walk test as a predictor of maximal exercise-induced gas exchange abnormalities in sarcoidosis. J Thorac Dis 2016;8:1995-2003. [PMID: 27621852 DOI: 10.21037/jtd.2016.06.39] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
48 Pimenta SP, Rocha RB, Baldi BG, Kawassaki Ade M, Kairalla RA, Carvalho CR. Desaturation - distance ratio: a new concept for a functional assessment of interstitial lung diseases. Clinics (Sao Paulo) 2010;65:841-6. [PMID: 21049210 DOI: 10.1590/s1807-59322010000900005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
49 José A, Dal Corso S. Reproducibility of the six-minute walk test and Glittre ADL-test in patients hospitalized for acute and exacerbated chronic lung disease. Braz J Phys Ther 2015;19:235-42. [PMID: 26039036 DOI: 10.1590/bjpt-rbf.2014.0092] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
50 Mancuzo EV, Soares MR, Pereira CAC. Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil. J Bras Pneumol 2018;44:267-72. [PMID: 30328926 DOI: 10.1590/S1806-37562018000000049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ishii H, Kinoshita Y, Kushima H, Nagata N, Watanabe K. The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis. Chron Respir Dis 2019;16:1479973119867945. [PMID: 31387379 DOI: 10.1177/1479973119867945] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Camillo CA, Langer D, Osadnik CR, Pancini L, Demeyer H, Burtin C, Gosselink R, Decramer M, Janssens W, Troosters T. Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes. Int J Chron Obstruct Pulmon Dis 2016;11:2671-9. [PMID: 27822029 DOI: 10.2147/COPD.S113450] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
53 Lilja-Maula LI, Laurila HP, Syrjä P, Lappalainen AK, Krafft E, Clercx C, Rajamäki MM. Long-term outcome and use of 6-minute walk test in West Highland White Terriers with idiopathic pulmonary fibrosis. J Vet Intern Med 2014;28:379-85. [PMID: 24417616 DOI: 10.1111/jvim.12281] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
54 Bloem AEM, Veltkamp M, Spruit MA, Custers JWH, Bakker EWP, Dolk HM, Grutters JC. Validation of 4-meter-gait-speed test and 5-repetitions-sit-to-stand test in patients with pulmonary fibrosis: a clinimetric validation study. Sarcoidosis Vasc Diffuse Lung Dis 2018;35:317-26. [PMID: 32476919 DOI: 10.36141/svdld.v35i4.7035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Swigris JJ, Swick J, Wamboldt FS, Sprunger D, du Bois R, Fischer A, Cosgrove GP, Frankel SK, Fernandez-Perez ER, Kervitsky D, Brown KK. Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest 2009;136:841-8. [PMID: 19395579 DOI: 10.1378/chest.09-0211] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
56 Stamm JA, Risbano MG, Mathier MA. Overview of current therapeutic approaches for pulmonary hypertension. Pulm Circ 2011;1:138-59. [PMID: 22034603 DOI: 10.4103/2045-8932.83444] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
57 Lammi MR, Baughman RP, Birring SS, Russell AM, Ryu JH, Scholand M, Distler O, LeSage D, Sarver C, Antoniou K, Highland KB, Kowal-Bielecka O, Lasky JA, Wells AU, Saketkoo LA. Outcome Measures for Clinical Trials in Interstitial Lung Diseases. Curr Respir Med Rev 2015;11:163-74. [PMID: 27019654 DOI: 10.2174/1573398X11666150619183527] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
58 Holland AE, Dowman L, Fiore J Jr, Brazzale D, Hill CJ, McDonald CF. Cardiorespiratory responses to 6-minute walk test in interstitial lung disease: not always a submaximal test. BMC Pulm Med 2014;14:136. [PMID: 25113781 DOI: 10.1186/1471-2466-14-136] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
59 Krishna BS, Mohapatra AK, Behera D, Jagaty SK, Subhankar S, Venkataram R, Dash DP. Six-Minute Walk Test and its Correlation with Spirometry in Stable COPD Patients. Journal of Health and Allied Sciences NU. [DOI: 10.1055/s-0041-1740331] [Reference Citation Analysis]
60 Agarwala P, Salzman SH. Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement. Chest 2020;157:603-11. [PMID: 31689414 DOI: 10.1016/j.chest.2019.10.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]